Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-18

Clinical Trial Update: A Clinical Study of Inhaled Nitric Oxide in Moderate-to-Severe Chronic Obstructive Pulmonary Disease [NA]

View source ↗

Summary

A clinical trial is investigating inhaled nitric oxide for moderate-to-severe chronic obstructive pulmonary disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Chronic Obstructive Pulmonary Disease | NA | Status: RECRUITING